NAMSW
NewAmsterdam Pharma Company N.V.
Set alert
8.98 USD -1.77 -16.42%
8.68 Day range 9.23
8.25 52-week range 29.99
- YTD
- -60.94%
- 1 year
- -67.09%
- Open
- 24.41
- Prev close
- 10.75
- Mkt cap
- 2.25B
- Vol
- 2.41K
- Avg vol
- 1.20K
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 8.68
- High
- 9.23
- Forward P/E
- 0.00
- Beta
- 0.10
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 11, 2026
- 50-d avg
- 12.22
- 200-d avg
- 19.03
- 1y target
- 0.00
1Y chart
Closing price and volume
Compare NAMSW
Chart and line up NAMSW against other symbols or a saved comparison set.
- NAMSW NewAmsterdam Pharma Company N.V.
8.98
-1.77 -16.42%
- SPY State Street SPDR S&P 500 ETF Trust
755.72
-13.64 -1.77%
- QQQ Invesco QQQ Trust
690.49
-24.85 -3.47%
Sign in to keep these symbols in a saved comparison set.
| Metric | NAMSW | SPY | QQQ |
|---|---|---|---|
| Last price | 8.98 | 755.72 | 690.49 |
| Change | -1.77 | -13.64 | -24.85 |
| Change % | -16.42% | -1.77% | -3.47% |
| Open | 24.41 | 761.38 | 697.13 |
| Day high | 9.23 | 761.46 | 698.63 |
| Day low | 8.68 | 750.36 | 683.45 |
| Previous close | 10.75 | 769.36 | 715.34 |
| Volume | 2.41K | 77.70M | 85.24M |
| Average volume | 1.20K | 41.22M | 34.57M |
| Market cap | 2.25B | 812.08B | 483.28B |
| P/E ratio | 0.00 | 23.99 | 26.44 |
| Earnings per share | 0.00 | 31.50 | 26.12 |
| Dividend yield | 0.00 | 0.00 | 0.00 |
| 52-week high | 29.99 | 779.09 | 759.66 |
| 52-week low | 8.25 | 631.97 | 558.28 |
| 1-week return | -2.87% | -0.559233% | -1.97% |
| 1-month return | -28.98% | -0.906075% | -6.66% |
| 3-month return | -46.23% | +1.89% | +1.02% |
| 6-month return | -57.68% | +5.16% | +3.41% |
| Year-to-date return | -60.94% | +10.82% | +12.40% |
| 1-year return | -67.09% | +11.16% | +10.29% |
| 2-year return | +3.27% | +32.90% | +42.71% |
| 50-day moving average | 12.22 | 767.63 | 725.41 |
| 200-day moving average | 19.03 | 728.53 | 679.17 |
| Target price | — | — | — |
| Beta | 0.10 | 0.00 | 0.00 |
| Short ratio | — | — | — |
| Institutional ownership | — | — | — |